Development of an artificial intelligence-derived histologic signature associated with adjuvant gemcitabine treatment outcomes in pancreatic cancer.

Of note, the RNA-seq cohorts also did not correlate with DSS among all TCGA patients with RNA-seq data, including those who did not receive adjuvant treatment or who received an adjuvant therapy other than gemcitabine, though there was a trend toward significance among Moffitt sub-sets ( Figure S7 ).

also in 3,729 other papers